Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health …

More What Aphria’s and Organigram’s Quarterly Updates Mean for Aurora Cannabis and Canopy Growth Videos